Soluble Interleukin-2 Receptors in the Serum of Patients with Hodgkin's Disease

Overview

Journal Br J Cancer

Specialty Oncology

Date 1987 Apr 1

PMID 3107607

Citations 13

Authors

G Pizzolo

M Chilosi

F Vinante

F Dazzi

M Lestani

G Perona

F Benedetti

G Todeschini

C Vincenzi

L Trentin

Affiliations

Soon will be listed here.

Citing Articles

Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes.

Seidler S, Zimmermann H, Weiskirchen R, Trautwein C, Tacke F BMC Gastroenterol. 2012; 12:38.

PMID: 22530792 PMC: 3434055. DOI: 10.1186/1471-230X-12-38.

Hematopoietic growth factor receptors.

Shieh J, Moore M Cytotechnology. 2012; 2(4):269-86.

PMID: 22358869 DOI: 10.1007/BF00364993.

Biological significance of soluble IL-2 receptor.

Caruso C, Candore G, Cigna D, Colucci A, Modica M Mediators Inflamm. 1993; 2(1):3-21.

PMID: 18475497 PMC: 2365387. DOI: 10.1155/S0962935193000018.

Mutations and regulatory anomalies effecting tumor cell immune functions.

Blanck G Cancer Immunol Immunother. 2003; 53(1):1-16.

PMID: 13680191 PMC: 11032877. DOI: 10.1007/s00262-003-0418-3.

Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.

Viviani S, Camerini E, Bonfante V, Santoro A, Balzarotti M, Fornier M Br J Cancer. 1998; 77(6):992-7.

PMID: 9528846 PMC: 2150083. DOI: 10.1038/bjc.1998.163.

References

Korsmeyer S, Greene W, Cossman J, Hsu S, Jensen J, Neckers L . Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proc Natl Acad Sci U S A. 1983; 80(14):4522-6. PMC: 384071. DOI: 10.1073/pnas.80.14.4522. View

Pizzolo G, Chilosi M, Semenzato G, Caligaris-Cappio F, FIORE-DONATI L, Perona G . Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's disease. Br J Cancer. 1984; 50(3):415-7. PMC: 1976791. DOI: 10.1038/bjc.1984.191. View

Hsu S, Yang K, Jaffe E . Phenotypic expression of Hodgkin's and Reed-Sternberg cells in Hodgkin's disease. Am J Pathol. 1985; 118(2):209-17. PMC: 1887864. View

Smith K, Cantrell D . Interleukin 2 regulates its own receptors. Proc Natl Acad Sci U S A. 1985; 82(3):864-8. PMC: 397147. DOI: 10.1073/pnas.82.3.864. View

STEIN H, Mason D, Gerdes J, OConnor N, Wainscoat J, Pallesen G . The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985; 66(4):848-58. View

Rubin L, Kurman C, FRITZ M, Biddison W, Boutin B, Yarchoan R . Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol. 1985; 135(5):3172-7. View

Frydecka I . Natural killer cell activity during the course of disease in patients with Hodgkin's disease. Cancer. 1985; 56(12):2799-803. DOI: 10.1002/1097-0142(19851215)56:12<2799::aid-cncr2820561215>3.0.co;2-w. View

Hooper W, Barth R, Shah N . Lack of natural killer cell activity in hairy cell leukemia patients and partial restoration with interleukin-2. Cancer. 1986; 57(5):988-93. DOI: 10.1002/1097-0142(19860301)57:5<988::aid-cncr2820570519>3.0.co;2-2. View

SCHEURLEN P, Schneider W, Pappas A . Inhibition of transformation of normal lymphocytes by plasma factor from patients with Hodgkin's disease and cancer. Lancet. 1971; 2(7736):1265. DOI: 10.1016/s0140-6736(71)90586-1. View

10.

KAMESAKI H, Fukuhara S, Tatsumi E, Uchino H, Yamabe H, Miwa H . Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin's disease. Blood. 1986; 68(1):285-92. View

11.

Chilosi M, Pizzolo G, Semenzato G, Cetto G . Detection of a soluble form of the receptor for interleukin 2 in the serum of patients with hairy cell leukaemia. Int J Biol Markers. 1986; 1(2):101-4. DOI: 10.1177/172460088600100208. View

12.

Farrar J, Benjamin W, Hilfiker M, Howard M, Farrar W . The biochemistry, biology, and role of interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell responses. Immunol Rev. 1982; 63:129-66. DOI: 10.1111/j.1600-065x.1982.tb00414.x. View